Since the clinical utility is limited by high cost of microarray analysis, many algorithms were introduced to stratify DLBCL based on the IHC expression profile of CD10, BCL-6, and MUM1 [3, 11]. Here, IRF4 is linked to diffuse large B-cell lymphoma.